OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
Endocrinology (2013) Vol. 154, Iss. 3, pp. 1260-1270
Open Access | Times Cited: 163
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
Endocrinology (2013) Vol. 154, Iss. 3, pp. 1260-1270
Open Access | Times Cited: 163
Showing 1-25 of 163 citing articles:
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
Yannick Waumans, Lesley Baerts, Kaat Kehoe, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 179
Yannick Waumans, Lesley Baerts, Kaat Kehoe, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 179
Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
Lucienne Juillerat‐Jeanneret
Journal of Medicinal Chemistry (2013) Vol. 57, Iss. 6, pp. 2197-2212
Closed Access | Times Cited: 188
Lucienne Juillerat‐Jeanneret
Journal of Medicinal Chemistry (2013) Vol. 57, Iss. 6, pp. 2197-2212
Closed Access | Times Cited: 188
DPP4 in Cardiometabolic Disease
Jixin Zhong, Andrei Maiseyeu, Stephen N. Davis, et al.
Circulation Research (2015) Vol. 116, Iss. 8, pp. 1491-1504
Open Access | Times Cited: 166
Jixin Zhong, Andrei Maiseyeu, Stephen N. Davis, et al.
Circulation Research (2015) Vol. 116, Iss. 8, pp. 1491-1504
Open Access | Times Cited: 166
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
Nina Wronkowitz, Sven W. Görgens, Tania Romacho, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1842, Iss. 9, pp. 1613-1621
Open Access | Times Cited: 138
Nina Wronkowitz, Sven W. Görgens, Tania Romacho, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1842, Iss. 9, pp. 1613-1621
Open Access | Times Cited: 138
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Tomoya Mita, Naoto Katakami, Hidenori Yoshii, et al.
Diabetes Care (2015) Vol. 39, Iss. 1, pp. 139-148
Open Access | Times Cited: 137
Tomoya Mita, Naoto Katakami, Hidenori Yoshii, et al.
Diabetes Care (2015) Vol. 39, Iss. 1, pp. 139-148
Open Access | Times Cited: 137
Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up‐regulated by hypoxia in human adipocytes and smooth muscle cells
Diana Röhrborn, Jürgen Eckel, Henrike Sell
FEBS Letters (2014) Vol. 588, Iss. 21, pp. 3870-3877
Open Access | Times Cited: 127
Diana Röhrborn, Jürgen Eckel, Henrike Sell
FEBS Letters (2014) Vol. 588, Iss. 21, pp. 3870-3877
Open Access | Times Cited: 127
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)
Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, et al.
Diabetes Care (2016) Vol. 39, Iss. 3, pp. 455-464
Open Access | Times Cited: 123
Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, et al.
Diabetes Care (2016) Vol. 39, Iss. 3, pp. 455-464
Open Access | Times Cited: 123
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
Yanmei Zeng, Chenzhong Li, Meiping Guan, et al.
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 119
Yanmei Zeng, Chenzhong Li, Meiping Guan, et al.
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 119
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system
Annayya R. Aroor, James R. Sowers, Guanghong Jia, et al.
AJP Heart and Circulatory Physiology (2014) Vol. 307, Iss. 4, pp. H477-H492
Open Access | Times Cited: 104
Annayya R. Aroor, James R. Sowers, Guanghong Jia, et al.
AJP Heart and Circulatory Physiology (2014) Vol. 307, Iss. 4, pp. H477-H492
Open Access | Times Cited: 104
DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
Yao Dai, Dongsheng Dai, Xianwei Wang, et al.
Cardiovascular Drugs and Therapy (2014) Vol. 28, Iss. 5, pp. 425-432
Closed Access | Times Cited: 103
Yao Dai, Dongsheng Dai, Xianwei Wang, et al.
Cardiovascular Drugs and Therapy (2014) Vol. 28, Iss. 5, pp. 425-432
Closed Access | Times Cited: 103
The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice
Marta Olivares, Audrey M. Neyrinck, Sarah A. Pötgens, et al.
Diabetologia (2018) Vol. 61, Iss. 8, pp. 1838-1848
Open Access | Times Cited: 85
Marta Olivares, Audrey M. Neyrinck, Sarah A. Pötgens, et al.
Diabetologia (2018) Vol. 61, Iss. 8, pp. 1838-1848
Open Access | Times Cited: 85
Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes
Ryo Kodera, Kenichi Shikata, Tetsuharu Takatsuka, et al.
Biochemical and Biophysical Research Communications (2013) Vol. 443, Iss. 3, pp. 828-833
Closed Access | Times Cited: 97
Ryo Kodera, Kenichi Shikata, Tetsuharu Takatsuka, et al.
Biochemical and Biophysical Research Communications (2013) Vol. 443, Iss. 3, pp. 828-833
Closed Access | Times Cited: 97
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
Enrique Z. Fisman, Alexander Tenenbaum
Cardiovascular Diabetology (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Enrique Z. Fisman, Alexander Tenenbaum
Cardiovascular Diabetology (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 81
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
Hyun‐Na Koo, Taeyang Yu, Dae Ho Lee
BioMed Research International (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 73
Hyun‐Na Koo, Taeyang Yu, Dae Ho Lee
BioMed Research International (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 73
Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
Katarina Tomović, Jelena Lazarević, Gordana Kocić, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 404-422
Open Access | Times Cited: 73
Katarina Tomović, Jelena Lazarević, Gordana Kocić, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 404-422
Open Access | Times Cited: 73
DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages
Christoph Brenner, Wolfgang-M. Franz, Sarah Kühlenthal, et al.
International Journal of Cardiology (2015) Vol. 199, pp. 163-169
Closed Access | Times Cited: 69
Christoph Brenner, Wolfgang-M. Franz, Sarah Kühlenthal, et al.
International Journal of Cardiology (2015) Vol. 199, pp. 163-169
Closed Access | Times Cited: 69
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
Ito H, Shinya Nishio, Mariko Abe
Diabetes Metabolic Syndrome and Obesity (2015), pp. 163-163
Open Access | Times Cited: 66
Ito H, Shinya Nishio, Mariko Abe
Diabetes Metabolic Syndrome and Obesity (2015), pp. 163-163
Open Access | Times Cited: 66
Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells
Taichi Shiobara, Kazuyuki Chibana, Taiji Watanabe, et al.
Respiratory Research (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Taichi Shiobara, Kazuyuki Chibana, Taiji Watanabe, et al.
Respiratory Research (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 62
A review of the anti‐inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes
Habib Yaribeygi, Stephen L. Atkin, Matteo Pirro, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8286-8294
Closed Access | Times Cited: 62
Habib Yaribeygi, Stephen L. Atkin, Matteo Pirro, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8286-8294
Closed Access | Times Cited: 62
DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome
Yochai Birnbaum, Dat Q. Tran, Mandeep Bajaj, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 5
Closed Access | Times Cited: 62
Yochai Birnbaum, Dat Q. Tran, Mandeep Bajaj, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 5
Closed Access | Times Cited: 62
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Allison B. Herman, Dimitrios Tsitsipatis, Carlos Anerillas, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 18
Allison B. Herman, Dimitrios Tsitsipatis, Carlos Anerillas, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 18
Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
Michishige Terasaki, Masaharu Nagashima, Kyoko Nohtomi, et al.
PLoS ONE (2013) Vol. 8, Iss. 8, pp. e70933-e70933
Open Access | Times Cited: 66
Michishige Terasaki, Masaharu Nagashima, Kyoko Nohtomi, et al.
PLoS ONE (2013) Vol. 8, Iss. 8, pp. e70933-e70933
Open Access | Times Cited: 66
Dipeptidyl Peptidase‐4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation
Taichi Ikedo, Manabu Minami, Hiroharu Kataoka, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 6
Open Access | Times Cited: 60
Taichi Ikedo, Manabu Minami, Hiroharu Kataoka, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 6
Open Access | Times Cited: 60
Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate
Dong‐Sung Lee, Eun-Sol Lee, Md. Morshedul Alam, et al.
Metabolism (2015) Vol. 65, Iss. 2, pp. 89-101
Closed Access | Times Cited: 58
Dong‐Sung Lee, Eun-Sol Lee, Md. Morshedul Alam, et al.
Metabolism (2015) Vol. 65, Iss. 2, pp. 89-101
Closed Access | Times Cited: 58
